BLACK DIAMOND THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Earnings Per Share, Basic and Diluted of -$0.63 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-25
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.63.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.50.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.41.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.51.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$2.05.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$16.99.
- BLACK DIAMOND THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$4.42.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.63 10-K · filed 2021-03-25 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$1.53 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$2.05 10-K · filed 2021-03-25 |
| 2020-09-30 | -$0.50 10-K · filed 2021-03-25 | -$0.90 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$1.42 10-Q · filed 2020-11-10 | -$2.23 derived: net income ÷ weighted average shares · filed 2021-11-08 |
| 2020-06-30 | -$0.41 10-K · filed 2021-03-25 | -$0.92 10-Q · filed 2020-08-11 | -$1.78 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$2.87 derived: net income ÷ weighted average shares · filed 2021-11-08 |
| 2020-03-31 | -$0.51 10-K · filed 2021-03-25 | -$1.70 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$3.36 derived: net income ÷ weighted average shares · filed 2021-11-08 | -$5.82 derived: net income ÷ weighted average shares · filed 2021-11-08 |
| 2019-12-31 | -$4.63 10-K · filed 2021-03-25 | -$9.10 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$15.07 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$16.99 10-K · filed 2021-03-25 |
| 2019-09-30 | -$4.50 10-K · filed 2021-03-25 | -$10.47 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$12.36 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$5.99 10-K · filed 2021-03-25 | -$7.86 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | -$1.87 10-K · filed 2021-03-25 | |||
| 2018-12-31 | -$1.51 10-K · filed 2020-03-24 | -$4.42 10-K · filed 2020-03-24 | ||
| 2018-09-30 | -$1.16 10-K · filed 2020-03-24 | |||
| 2018-06-30 | -$0.95 10-K · filed 2020-03-24 | |||
| 2018-03-31 | -$0.80 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |